0,931  0,002  Genotoxic
0,889  0,004  Mutagenic
0,816  0,006  Carcinogenic
0,813  0,009  Caspase 9 stimulant
0,764  0,004  UGT1A9 substrate
0,723  0,002  Cystathionine beta-synthase inhibitor
0,727  0,026  Apoptosis agonist
0,703  0,004  Carcinogenic, group 3
0,684  0,004  Sulfotransferase substrate
0,672  0,004  Antiseptic
0,673  0,010  Sensitization
0,664  0,006  UGT1A6 substrate
0,646  0,005  UDP-glucuronosyltransferase substrate
0,632  0,009  NOS2 expression inhibitor
0,622  0,010  Cytostatic
0,619  0,012  CTGF expression inhibitor
0,628  0,021  Antileukemic
0,601  0,005  Calcium channel L-type activator
0,621  0,027  CYP3A4 substrate
0,595  0,007  Antimutagenic
0,584  0,005  UGT1A3 substrate
0,578  0,009  DNA damaging
0,598  0,030  Antineoplastic (lung cancer)
0,598  0,035  Antineoplastic (breast cancer)
0,566  0,014  Antioxidant
0,568  0,017  CYP1A2 substrate
0,572  0,026  Teratogen
0,572  0,030  TNF expression inhibitor
0,558  0,016  12-Lipoxygenase inhibitor
0,575  0,034  Transcription factor NF kappa B inhibitor
0,553  0,016  Chemopreventive
0,543  0,011  CYP1A2 inhibitor
0,559  0,028  Antineoplastic (colorectal cancer)
0,533  0,006  Topoisomerase II inhibitor
0,549  0,027  Antineoplastic (colon cancer)
0,528  0,017  Caspase 3 stimulant
0,538  0,031  Antibacterial
0,518  0,014  Free radical scavenger
0,522  0,030  Aldehyde oxidase inhibitor
0,518  0,029  Embryotoxic
0,507  0,018  Lipoxygenase inhibitor
0,506  0,024  Cytotoxic
0,493  0,011  RNA-directed DNA polymerase inhibitor
0,481  0,009  UGT1A4 substrate
0,480  0,010  Radiosensitizer
0,475  0,005  Glutathione S-transferase substrate
0,496  0,028  Antineoplastic (ovarian cancer)
0,489  0,025  Antineoplastic (melanoma)
0,474  0,011  UGT1A1 substrate
0,484  0,023  AR expression inhibitor
0,464  0,004  SULT1A3 substrate
0,462  0,005  UGT2B15 substrate
0,476  0,025  Antineoplastic (cervical cancer)
0,487  0,043  15-Lipoxygenase inhibitor
0,462  0,017  UGT2B4 substrate
0,516  0,076  Alpha-glucosidase inhibitor
0,457  0,018  Antineoplastic (lymphoma)
0,445  0,012  Calcium channel activator
0,456  0,027  Antineoplastic (pancreatic cancer)
0,442  0,013  Antineoplastic (small cell lung cancer)
0,455  0,027  Antineoplastic (brain cancer)
0,450  0,023  Proliferative diseases treatment
0,429  0,005  Neurotrophic factor enhancer
0,426  0,003  Photosensitizer
0,428  0,008  Amylase inhibitor
0,430  0,012  Antineoplastic (bladder cancer)
0,435  0,023  Hypoxia-inducible factor 1 alpha inhibitor
0,416  0,007  Alkylator
0,448  0,042  Prostate cancer treatment
0,438  0,036  Antihypercholesterolemic
0,400  0,003  NAD(P)H dehydrogenase (quinone) inhibitor
0,488  0,093  Antiinflammatory
0,421  0,031  Chemoprotective
0,415  0,025  Hypoglycemic
0,426  0,038  Antifungal
0,385  0,006  Carcinogenic, group 2B
0,398  0,022  DNA synthesis inhibitor
0,399  0,025  Antihypoxic
0,378  0,006  Topoisomerase I inhibitor
0,377  0,006  Antineoplastic antibiotic
0,400  0,030  Antiprotozoal (Leishmania)
0,376  0,008  DNA intercalator
0,389  0,024  Antineoplastic (osteosarcoma)
0,400  0,036  Antineoplastic (glioma)
0,373  0,013  Mcl-1 antagonist
0,413  0,056  GABA C receptor rho-3 antagonist
0,360  0,007  Aldehyde dehydrogenase inhibitor
0,369  0,018  Dual specificity phosphatase inhibitor
0,390  0,041  NOS3 expression inhibitor
0,382  0,036  Antineoplastic (non-small cell lung cancer)
0,386  0,041  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,411  0,070  Histamine release inhibitor
0,367  0,027  Antineoplastic (endocrine cancer)
0,383  0,047  ICAM1 expression inhibitor
0,378  0,043  Cardioprotectant
0,350  0,019  Hepatoprotectant
0,394  0,065  CYP2C9 substrate
0,378  0,050  Hepatic disorders treatment
0,342  0,017  Skin whitener
0,337  0,015  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,339  0,019  UGT2B7 substrate
0,330  0,012  Antidote
0,388  0,071  Prostaglandin dehydrogenase inhibitor
0,347  0,032  Nitric oxide antagonist
0,320  0,006  Topoisomerase II alpha inhibitor
0,322  0,009  Hexokinase inhibitor
0,349  0,035  Myocardial infarction treatment
0,351  0,039  Sodium/bile acid cotransporter inhibitor
0,342  0,031  Antineoplastic (lymphocytic leukemia)
0,331  0,022  Antihypotensive
0,339  0,030  Antihypertriglyceridemic
0,379  0,075  GST A substrate
0,365  0,060  Bone diseases treatment
0,333  0,030  Antineoplastic enhancer
0,292  0,004  CDC25A inhibitor
0,307  0,020  Antineoplastic (squamous cell carcinoma)
0,290  0,005  SULT1A1 substrate
0,296  0,012  Nitric-oxide synthase stimulant
0,292  0,010  Aldose reductase substrate
0,298  0,019  Protein-tyrosine phosphatase inhibitor
0,314  0,039  Antiparasitic
0,278  0,005  Estrogen receptor alpha antagonist
0,376  0,105  Cyclophilin D inhibitor
0,376  0,105  Antidiabetic
0,282  0,012  5-Lipoxygenase inhibitor
0,290  0,020  Lipid peroxidase inhibitor
0,306  0,036  Peroxidase inhibitor
0,300  0,033  Antiviral (HIV)
0,277  0,010  Antihemorrhagic
0,280  0,013  Heat shock protein 90 antagonist
0,305  0,040  Cyclic AMP phosphodiesterase inhibitor
0,308  0,045  Antineoplastic (glioblastoma multiforme)
0,303  0,040  Antineoplastic (sarcoma)
0,275  0,013  Antiprotozoal (Coccidial)
0,328  0,067  Apoptosis antagonist
0,306  0,046  Vasodilator
0,337  0,078  Antineoplastic (non-Hodgkin's lymphoma)
0,331  0,073  Cholesterol antagonist
0,311  0,053  Antipyretic
0,280  0,023  Interferon gamma antagonist
0,262  0,006  Estrogen receptor beta antagonist
0,327  0,072  FMO1 substrate
0,345  0,090  Immunosuppressant
0,297  0,050  Angiogenesis stimulant
0,251  0,006  HIV-1 integrase (Strand Transfer) inhibitor
0,253  0,008  Estrogen antagonist
0,311  0,066  Interleukin 2 agonist
0,297  0,053  Antidiabetic symptomatic
0,266  0,023  Protein kinase stimulant
0,313  0,071  Antimycobacterial
0,253  0,011  Antibacterial (Helicobacter pylori)
0,304  0,065  Radioprotector
0,294  0,056  Transcription factor STAT3 inhibitor
0,250  0,013  Interleukin 4 antagonist
0,273  0,035  VCAM1 expression inhibitor
0,259  0,023  Monophenol monooxygenase inhibitor
0,238  0,007  HIV-1 integrase (3'-Processing) inhibitor
0,290  0,061  Antiprotozoal (Trypanosoma)
0,230  0,004  Thioredoxin reductase inhibitor
0,255  0,029  Antineoplastic (carcinoma)
0,283  0,057  Interleukin agonist
0,250  0,026  NOS3 expression enhancer
0,292  0,070  Antiosteoporotic
0,259  0,039  P-glycoprotein inhibitor
0,296  0,078  Respiratory analeptic
0,283  0,066  Transcription factor STAT inhibitor
0,232  0,015  Catenin beta inhibitor
0,229  0,015  Xanthine oxidase inhibitor
0,224  0,010  Coagulant
0,255  0,043  Antihelmintic
0,242  0,032  Antineoplastic (gastric cancer)
0,272  0,063  Antineoplastic (liver cancer)
0,263  0,056  Tyrosine 3 hydroxylase inhibitor
0,252  0,046  Antiviral (Influenza)
0,228  0,027  Alpha-N-acetylglucosaminidase inhibitor
0,212  0,015  Choleretic
0,269  0,075  GST M1-1 substrate
0,279  0,085  Immunostimulant
0,326  0,134  Antiarthritic
0,254  0,067  Cardiodepressant
0,258  0,073  5 Hydroxytryptamine uptake stimulant
0,194  0,010  Actinic keratosis treatment
0,210  0,026  Protein-tyrosine phosphatase 1B inhibitor
0,216  0,032  Skin irritative effect
0,190  0,008  SULT1E1 substrate
0,214  0,033  Tubulin antagonist
0,217  0,036  Antiviral (Influenza A)
0,193  0,013  Porphobilinogen synthase inhibitor
0,227  0,049  Insulin sensitizer
0,199  0,022  CF transmembrane conductance regulator agonist
0,208  0,031  UGT2B10 substrate
0,207  0,031  Antirickettsial
0,228  0,052  Pneumotoxic
0,279  0,104  Antithrombotic
0,187  0,013  Antiviral (Influenza B)
0,188  0,014  Histidine decarboxylase inhibitor
0,299  0,126  CYP2C19 inhibitor
0,183  0,014  Creatine kinase inhibitor
0,175  0,005  CDC25B inhibitor
0,295  0,127  Antiprotozoal
0,200  0,032  Antifungal enhancer
0,283  0,117  Stroke treatment
0,184  0,019  UGT2B1 substrate
0,192  0,027  Toll-Like receptor 2 antagonist
0,211  0,047  Eye irritation, high
0,260  0,100  Analeptic
0,239  0,079  Cardiovascular analeptic
0,199  0,041  Melanin inhibitor
0,237  0,080  Acute neurologic disorders treatment
0,170  0,013  Ca2+-transporting ATPase inhibitor
0,203  0,049  Antihelmintic (Nematodes)
0,207  0,054  Antiviral (Hepatitis)
0,179  0,027  MAP3K9 inhibitor
0,213  0,061  Non-steroidal antiinflammatory agent
0,184  0,034  DNA polymerase I inhibitor
0,319  0,169  Antineoplastic (solid tumors)
0,197  0,048  Antiviral (Herpes)
0,206  0,057  Dual specificity phosphatase 3 inhibitor
0,156  0,008  HIV-1 integrase inhibitor
0,198  0,050  Succinate dehydrogenase inhibitor
0,305  0,159  5 Hydroxytryptamine release inhibitor
0,183  0,040  Alkaline phosphatase inhibitor
0,278  0,135  CYP2C9 inhibitor
0,172  0,030  Chelator
0,165  0,024  UDP-glucose 4-epimerase inhibitor
0,242  0,102  Antineoplastic (multiple myeloma)
0,153  0,014  Paget's disease treatment
0,207  0,068  Platelet adhesion inhibitor
0,153  0,014  Keratolytic
0,204  0,067  DNA methyltransferase I inhibitor
0,163  0,026  Carbonic anhydrase XV inhibitor
0,188  0,051  Antineoplastic (bone cancer)
0,147  0,010  Leukotriene synthesis inhibitor
0,152  0,016  Thioredoxin inhibitor
0,172  0,036  Antiviral (Hepatitis B)
0,161  0,027  Alcohol dehydrogenase substrate
0,158  0,026  Antineoplastic, alkylator
0,163  0,031  Expectorant
0,258  0,126  Vasodilator, coronary
0,157  0,028  Antineoplastic (uterine cancer)
0,186  0,058  Heat shock protein 90 alpha antagonist
0,193  0,067  VEGF expression inhibitor
0,152  0,027  AMP-activated protein kinase stimulant
0,150  0,025  Multidrug resistance-associated protein 1 inhibitor
0,145  0,021  Anabolic
0,174  0,050  MAO inhibitor
0,128  0,005  Heat shock protein 90 beta antagonist
0,151  0,030  DNA repair enzyme inhibitor
0,226  0,107  Antituberculosic
0,139  0,020  UGT2B11 substrate
0,168  0,049  Cell wall synthesis inhibitor
0,143  0,028  HIV-1 integrase (Overall Integration) inhibitor
0,140  0,025  Carcinogenic, group 2A
0,137  0,022  Antibiotic
0,174  0,059  Acaricide
0,157  0,043  Cyclooxygenase 3 inhibitor
0,147  0,034  Mucolytic
0,210  0,097  Aryl hydrocarbon receptor agonist
0,195  0,082  DNA methylase inhibitor
0,263  0,150  Antipruritic, allergic
0,139  0,028  DOPA decarboxylase inhibitor
0,117  0,007  Topoisomerase II beta inhibitor
0,148  0,039  Microtubule formation inhibitor
0,123  0,014  Estrogen agonist
0,218  0,110  Lipoprotein disorders treatment
0,250  0,142  Ulceration
0,119  0,014  Aldose reductase inhibitor
0,157  0,052  Adenylate cyclase stimulant
0,123  0,020  Glutamate release inhibitor
0,135  0,033  Chronic obstructive bronchitis treatment
0,245  0,144  Antiprotozoal (Plasmodium)
0,165  0,063  UGT2B9 substrate
0,206  0,106  Antineoplastic (renal cancer)
0,128  0,028  Triose-phosphate isomerase inhibitor
0,124  0,027  NADH dehydrogenase inhibitor
0,109  0,014  Alpha tubulin antagonist
0,145  0,052  Antihelmintic (Trematoda)
0,190  0,096  Antialcoholic
0,121  0,030  ABCA1 expression enhancer
0,123  0,033  Alcohol dehydrogenase inhibitor
0,128  0,038  Beta glucuronidase inhibitor
0,116  0,028  Antiviral (Trachoma)
0,103  0,015  Antidote, heavy metal
0,193  0,105  Antiamyloidogenic
0,119  0,032  Antispirochetal
0,114  0,028  Telomerase inhibitor
0,179  0,094  Pyruvate kinase inhibitor
0,151  0,067  Hemostatic
0,096  0,012  Estrogen receptor beta agonist
0,093  0,009  Estrogen receptor alpha agonist
0,175  0,092  CYP2B6 inhibitor
0,096  0,014  Antimycoplasmal
0,156  0,074  Carcinogenic, group 1
0,195  0,114  Tumour necrosis factor alpha release inhibitor
0,129  0,048  MAO A inhibitor
0,136  0,056  Vanilloid 1 agonist
0,101  0,022  Beta tubulin antagonist
0,096  0,017  Xanthine dehydrogenase inhibitor
0,199  0,120  Spasmolytic
0,173  0,095  Abortion inducer
0,121  0,043  Carbonic anhydrase III inhibitor
0,116  0,041  Prolactin inhibitor
0,205  0,130  Streptokinase A inhibitor
0,089  0,014  Fatty acid synthase inhibitor
0,123  0,049  Antiviral (Poxvirus)
0,149  0,075  GABA C receptor rho-2 antagonist
0,100  0,028  Cyclin B3 inhibitor
0,203  0,131  Antidiabetic (type 2)
0,136  0,065  NADPH oxidase inhibitor
0,257  0,187  DNA directed DNA polymerase inhibitor
0,116  0,047  Bronchodilator
0,135  0,066  Cyclooxygenase 1 inhibitor
0,188  0,120  Vascular (periferal) disease treatment
0,083  0,015  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,095  0,028  SULT1A2 substrate
0,178  0,111  Hypolipemic
0,152  0,087  Arachidonic acid antagonist
0,123  0,058  Antifungal (Pneumocystis)
0,163  0,099  Amyloid beta aggregation inhibitor
0,157  0,093  Antipruritic, non-allergic
0,086  0,022  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,095  0,032  Glutamate decarboxylase inhibitor
0,083  0,022  Androgen agonist
0,100  0,039  Carbonic anhydrase VI inhibitor
0,126  0,067  Antiviral (Papilloma)
0,125  0,067  M18 aspartyl aminopeptidase inhibitor
0,099  0,041  ATPase (Vacuolar H+) inhibitor
0,136  0,079  Mannose-6-phosphate isomerase inhibitor
0,112  0,058  Electron transport complex I inhibitor
0,138  0,087  Antidiarrheal
0,068  0,016  Estradiol 17 beta-dehydrogenase inhibitor
0,088  0,037  Phosphofructokinase-1 inhibitor
0,099  0,048  Androgen antagonist
0,068  0,020  Antibiotic Glycopeptide-like
0,097  0,049  Antidote, mercury
0,189  0,142  Antiviral (West Nile virus)
0,053  0,007  ATP citrate lysase inhibitor
0,210  0,165  Vasodilator, peripheral
0,088  0,044  Phosphodiesterase 3A inhibitor
0,087  0,044  Na+ K+ transporting ATPase inhibitor
0,142  0,102  Antiviral (Hepatitis C)
0,072  0,033  Aromatase inhibitor
0,117  0,078  Sphingosine 1-phosphate receptor 4 antagonist
0,076  0,038  Anticholelithogenic
0,099  0,060  MAO B inhibitor
0,146  0,109  Sedative
0,189  0,153  CYP2D6 substrate
0,095  0,058  GST P1-1 substrate
0,044  0,008  Sodium/glucose cotransporter 2 inhibitor
0,080  0,044  Glutamate dehydrogenase inhibitor
0,053  0,018  Guanylate cyclase inhibitor
0,064  0,030  Postmenopausal disorders treatment
0,042  0,008  Liver X receptor alpha antagonist
0,130  0,096  Insulin secretagoues
0,101  0,067  Gout treatment
0,056  0,023  Glucose-6-phosphate isomerase inhibitor
0,094  0,061  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,173  0,141  Peptidyltransferase inhibitor
0,048  0,017  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,092  0,062  Uric acid excretion stimulant
0,051  0,022  Liver X receptor agonist
0,041  0,013  Liver X receptor antagonist
0,101  0,073  GST T1-1 substrate
0,145  0,118  LDLR expression enhancer
0,142  0,115  ATPase inhibitor
0,116  0,090  Bone formation stimulant
0,047  0,022  DNA gyrase subunit A inhibitor
0,085  0,060  Transcription factor NF kappa B stimulant
0,085  0,062  Ornithine decarboxylase inhibitor
0,189  0,166  Gastrin inhibitor
0,112  0,090  Antihyperlipoproteinemic
0,031  0,009  Vanilloid 2 agonist
0,180  0,157  CYP2C19 substrate
0,032  0,010  Sodium/glucose cotransporter inhibitor
0,036  0,015  Estrogen-related receptor beta antagonist
0,044  0,023  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,078  0,058  Xanthine oxidase substrate
0,082  0,063  D-Ala-D-Ala ligase inhibitor
0,031  0,012  Protein 30S ribosomal subunit inhibitor
0,085  0,067  Aminoacyl-tRNA synthetase inhibitor
0,056  0,039  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,028  0,010  Dopamine D1 agonist
0,021  0,004  Antibiotic Tetracycline-like
0,080  0,064  Antiviral (Dengue virus)
0,087  0,070  Breast cancer-resistant protein inhibitor
0,108  0,093  Cyclooxygenase 2 inhibitor
0,022  0,008  Antibiotic Anthracycline-like
0,094  0,079  HDL-cholesterol increasing
0,027  0,013  Sodium/glucose cotransporter 1 inhibitor
0,042  0,028  Liver X receptor alpha agonist
0,116  0,104  Cyclooxygenase inhibitor
0,092  0,082  Adenylate kinase inhibitor
0,116  0,107  Sphingosine 1-phosphate receptor 2 antagonist
0,095  0,087  GABA C receptor antagonist
0,023  0,015  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,105  0,099  Contraceptive female
0,025  0,019  Thyroid hormone agonist
0,034  0,028  Antibiotic Aminoglycoside-like
0,034  0,028  Ceramide glucosyltransferase inhibitor
0,037  0,032  Retinoic acid alpha receptor agonist
0,073  0,068  MAP kinase kinase 7 inhibitor
0,050  0,045  Alcohol oxidase inhibitor
0,065  0,060  SULT2A1 substrate
0,065  0,061  Cathepsin G inhibitor
0,102  0,099  Antiacne
0,103  0,100  Acetylcholinesterase inhibitor
0,055  0,052  Cyclin D1 inhibitor
0,109  0,108  Antiprotozoal (Trichomonas)

